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ABSTRACT SP-BCTERM, a cationic, helical peptide based on the essential lung surfactant protein B (SP-B), retains a signiﬁcant
fraction of the function of the full-length protein. Solid-state 2H- and 31P-NMR were used to examine the effects of SP-BCTERM on
mechanically oriented lipid bilayer samples. SP-BCTERM modiﬁed the multilayer structure of bilayers composed of POPC, POPG,
POPC/POPG, or bovine lipid extract surfactant (BLES), even at relatively low peptide concentrations. The 31P spectra of BLES,
which contains ~1% SP-B, and POPC/POPG with 1% SP-BCTERM, look very similar, supporting a similarity in lipid interactions of
SP-BCTERM and its parent protein, full-length SP-B. In the model systems, although the peptide interacted with both the oriented
and unoriented fractions of the lipids, it interacted differently with the two fractions, as demonstrated by differences in lipid head-
group structure induced by the peptide. On the other hand, although SP-BCTERM induced similar disruptions in overall bilayer
orientation in BLES, there was no evidence of lipid headgroup conformational changes in either the oriented or the unoriented
fractions of the BLES samples. Notably, in the model lipid systems the peptide did not induce the formation of small, rapidly
tumbling lipid structures, such as micelles, or of hexagonal phases, the observation of which would have provided support for
functional mechanisms involving peptide-induced lipid ﬂip-ﬂop or stabilization of curved lipid structures, respectively.INTRODUCTION
Lung surfactant (LS) is a mixture of lipids and proteins that is
essential for reducing surface tension at the air-aqueous inter-
face during breathing (1,2). It is secreted from alveolar type II
cells and transferred into the aqueous layer lining the alveoli,
where it forms a surfacemonolayerwith underlyingmultilayer
structures (3). Approximately 90% by weight of surfactant
is lipid, mainly phosphocholine (PC) and phosphoglycerol
(PG), and 10% is surfactant proteins (SPs) (4,5). To date,
four proteins, designated by their chronologic order of
discovery as SP-A, SP-B, SP-C, and SP-D, have been identi-
fied. Proteins SP-A and SP-D are large, hydrophilic oligomers
that possess activities against bacteria or viruses and thus
provide important host defense functions (4,6–8). Although
SP-A can affect surfactant lipid organization, it plays less crit-
ical roles in surface activity than the small hydrophobic
proteins SP-B and SP-C, whereas SP-D has no known surface
activity at all (9). Both SP-B andSP-Cpromote adsorption and
spreading of phospholipids into the air-aqueous interface
(3,10), and also influence the organization and readsorption
of the multilayer structures thought to be important as reser-
voirs during inspiration/expiration cycling (11). Of all the
LS proteins, SP-B leads to the largest reductions in surface
tensions (12) and is the only LS protein that is essential for
life (4,13,14).
SP-B is highly conserved in mammalian species (6) and
possesses 79 amino acid residues per monomer. Six cysteines
form three intramolecular disulfide bonds, and the seventh
one forms an intermolecular bridge to stabilize the SP-B
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0006-3495/09/05/3762/10 $2.00homodimer structure (15,16). SP-B contains a predominantly
a-helical conformation as determined by circular dichroism
and Fourier transform infrared spectroscopy (17,18). High-
resolution structures of several subsegments of SP-B have
been determined by solution NMR spectroscopy: these
include an N-terminal SP-B (SP-B11–25) peptide in methanol
solution (19), the C-terminus of SP-B (SP-B63–78) in hexa-
fluoro-2-propanol organic solvent and sodiumdodecyl sulfate
(SDS) micelles (20), and Mini-B, a 34-residue peptide con-
taining both N- and C-terminal regions of SP-B, in SDS
micelles (21). All of these peptides display a high proportion
of amphipathic a-helix conformation. Several fragments of
SP-B containing one or more of its helices have been shown
to retain a significant portion of the function of full-length
SP-B in in vitro and in vivo studies (22–26). SP-B63–78 retains
almost half the activity of full-length SP-B, as judged by
in vivo studies in surfactant deficient rats (26) (A. Waring
and F. Walther, University of California, Los Angeles,
personal communication, 2007).
The C-terminal peptide, SP-B63–78 or SP-BCTERM,
employed in this study has 16 residues with a net charge
of þ3 as compared to the full-length protein, which has
a charge ofþ7 (per monomer) at neutral pH. It has been sug-
gested that the function of SP-B is related to its positive
charges and amphipathic helical structure (27,28). The
C-terminal region of SP-B formed a basis for the design of
the 21-residue peptide KL4 (29), which has shown promise
as a synthetic replacement for SP-B in clinical trials (30,31).
Although it is thought that SP-B plays critical roles in accel-
erating or stabilizing the formation of surface activemonolayer
films, a detailed mechanistic understanding of all the complex
interactions between the lipid and protein components that
doi: 10.1016/j.bpj.2009.02.027
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LS is found both in monolayer structures at the air/water inter-
face and in the multilayer structures that are closely associated
with the interfacial monolayer. Although many mechanisms
for SP-B have been proposed, several center around its poten-
tial role in promoting the organization of the lipids into
specific, functional structures (32,33). For example, SP-B
has been proposed to hold hypophase multilayer structures
in close association with the surface monolayer by interacting
with both structures (32). It has also been hypothesized that
SP-B might promote fusion of the multilayer structures with
themonolayer by stabilizing negatively curved lipid structures
in the neck region of the fusion structure (11). Additionally,
there have been some suggestions that SPs, including SP-B,
may promote lipid adsorption to the surface by inducing flip-
flop of lipids (34,35). In this study, SP-BCTERM’s ability to
manipulate multilayer structures was probed by monitoring
the peptide-induced changes in NMR spectra of mechanically
aligned lipid bilayers. Unlike multilamellar dispersions,
oriented bilayers provide information on large-scale lipid orga-
nization, as well as on lipid acyl chain order and headgroup
orientation in both the oriented and peptide-disrupted fractions
of the sample. In addition to revealing SP-BCTERM’s effect on
the overall lipid organization, the NMR spectra would have
indicated the formation of any hexagonal phase material.
Such an observation would support a role for the peptide in
inducing highly curved bilayer structures such as those seen
in fusion-neck regions, or the presence of rapidly reorienting
species that could support a role for SP-B in inducing lipid
flip-flop (34,35).
Although LS is composed of a complex mix of lipids, two-
component mixtures composed of a ratio of 7:3 PC/PG have
been shown to successfully mimic many of the characteristic
of LS (36,37), and have been used in artificial surfactant
(ALEC) (38,39). The saturated lipid dipalmitoylphosphati-
dylcholine (DPPC) is generally considered to be of paramount
importance in attaining low surface tensions, although, for
example, in bovine LS, the amounts of DPPC and unsaturated
PC are approximately equal (11), and there are some organ-
isms with functioning LS that contain quite low levels of
DPPC (40). In this study, it was deemed more advantageous
to employ POPC rather than DPPC in the model lipid systems
to focus on the effects of headgroup composition and to avoid
complications due to the high liquid crystal phase to gel phase
transition temperature of DPPC, and consequent difficulties
with maintaining sample hydration. Our study employed
a mixture of 7:3 1-palmitoyl-2-oleoyl-sn-glycero-3-phospho-
choline (POPC) to 1-palmitoyl-2-oleoyl-sn-glycero-3-phos-
phoglycerol (POPG), aswell as POPC alone and POPGalone.
The work was extended to include DPPC, as well as most
other components of LS, by repeating the experiments with
bovine lipid extract surfactant (BLES), which is prepared
from endotracheal lavage of cow lungs (41). BLES is an LS
that is used clinically and contains all the normal components
of LS, except for cholesterol and other neutral lipids, aswell asthe hydrophilic LS proteins SP-A and SP-D, which are
removed.
MATERIALS AND METHODS
Materials
SP-BCTERM (NH2-GRMLPQLVCRLVLRCS-COOH), a peptide consisting
of residues 63–78 of human SP-B, was synthesized via solid phase methods
employing O-fluorenylmethyl-oxycarbonyl (Fmoc) chemistry, and purified
using HPLC as previously described (20). POPC, POPC-d31, POPG, and
POPG-d31 were purchased from Avanti Polar Lipids (Alabaster, AL) and
used as received. BLES was a gift from BLES Biochemicals (London,
Canada) and was used after an additional CH3OH/CHCl3 extraction based
on Bligh and Dyer methods (42), with concentration determined by UV
absorption at 815 nm. Muscovite mica (grade V-4, dimension: 75  25 
0.26 mm3) was purchased from Structure Probe (West Chester, PA) and cut
into smaller pieceswith dimension 12.5mm 5mmand thickness of ~40mm.
Preparation of oriented samples
Peptide and 4 mg of lipids or BLES were codissolved in a solvent composed
of CH3OH/CHCl3 (1:1 by volume), without buffer or salt. The secondary
structure of the peptide in this solution is a-helical, as confirmed by circular
dichroism (see Fig. S1 in the Supporting Material). In all samples except for
those containing BLES, 30% (by weight) of the lipids were deuterated, i.e.,
7:3 POPC/POPC-d31, 7:3 POPG/POPG-d31, or 7:3 POPC/POPG-d31. The
2H and 31P spectra for each particular peptide/lipid (P/L) composition
were obtained with exactly the same sample. The concentration of P/L is
expressed in percentage, based on their weights. The solution, with a total
volume of ~250 mL, was spread homogeneously with care on 12 mica plates.
The unstacked plates were dried for ~2 h in a fume hood and then placed
in a vacuum chamber overnight. Each plate was then spread with several
microliters of double-distilled water and put in a hydration chamber with
saturated ammonia phosphate solution at 4C for at least 3 days. The plates
were then stacked together, wrapped with plastic film, and sealed with poly-
styrene plastic. Samples were stored at 4C before and after use. Since
double-distilled water rather than deuterium-depleted water was used to
hydrate the samples, the 2H-NMR signal contribution from double-distilled
water was examined and found to be negligible compared to the signal from
2H-labeled lipid (<30 times the intensity of the CD3 peak; data not shown).
Several samples were subjected to thin film chromatography and the lipids
showed a single spot (data not shown), indicating that the bilayer orientation
disruption observed was not the result of lipid hydrolysis.
NMR experiments
The spectra were acquired on a Bruker (Billerica, MA) Avance II 14.1 Tesla
solid-state NMR spectrometer at a temperature of 293 K and operated at reso-
nance frequencies of 243.02 MHz and 92.15 MHz for nuclei 31P and 2H,
respectively. Except where noted, each spectrum was acquired with the
bilayer normal parallel to the external magnetic field, using the average of
8192–10,240 transients with spectral line-broadening of 100 Hz applied
during processing. For 31P experiments, the samplewas inserted into aBruker
dual-tuned cross-polarization flat coil probe. A spin-echo pulse sequence (p/
2-t-p-acq) was applied, with ap/2 pulse length of 12ms, a delay t of 2ms, and
a recycle delay of 3 s. The spectral width was 184 ppm, with SPINAL-64
proton decoupling at a strength of 60 kHz (43). The chemical shift was exter-
nally referenced to 85% H3PO4 as 0 ppm. It has been shown that for oriented
samples such as these,with<100mgofmica, the chemical shift deviation due
to the nonspherical geometry of the sample is <1 ppm (44). For 2H experi-
ments, the sample was inserted into a Bruker triple-tuned cross-polarization
flat coil probe. A quadrupole echo pulse sequence (p/2-t-p/2-acq) (45) was
used with p/2 and t set at 2.5 ms and 15 ms, respectively. The spectral width
was 200 kHz, with a recycle delay of 1 s.Biophysical Journal 96(9) 3762–3771
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determination
To examine the effect of the peptide on orientational order at different points
along the POPC lipid chain, the peaks in the 2H-NMR spectra were assigned
to the appropriate carbon positions along the (sn1) acyl chain. The innermost
pair is assigned to the methyl group (C16) deuterons at the tail end of the
lipids, which have the least constrained motion. The pair with the second
smallest splitting is assigned to deuterons (on C15) next to the methyl group,
and so on for deuterons on C14 and C13. In the region of the spectra with
wider splittings (the plateau region), the doublets overlap. For these reso-
nances, the dependence of orientational order on position can be estimated
using the smoothed order parameter profile approach (46). In this approach,
the peak positions are estimated by dividing the area of the spectrum corre-
sponding to deuterons on C12 to C2 into 11 equal parts and assuming that
the quadrupole splitting changes monotonically with position along the
chain.
Note that both of these assignment approaches could be applied even
to most of the 2H spectra that exhibited contributions from unoriented
lipid components. Although the unoriented fraction of the sample contrib-
uted some broad intensity to the central region, the C16-C13 peaks from
the oriented portion of the sample could be clearly identified for all but
the POPG/peptide samples. Since the unoriented portion of the sample
does not contribute to the intensity in the wider (plateau) region of the
spectra, the smoothed order parameter approach could still be applied
for C12-C2.
Using the deuteron assignment scheme described above, the order
parameter of the lipid chains was probed at different positions along the
chains. For the oriented bilayer spectral component, the quadrupole split-
ting DnCD
i of deuterons on a lipid acyl chain at the i-th carbon position
is given by
DviCD ¼
3vCD
2
SiCD
; (1)
where nCD is the quadrupole coupling constant of deuterium, given by 167
kHz in deuterated paraffin hydrocarbons (47), and SiCD is the C-D bond order
parameter in the i-th segment. It can be expressed as
SiCD ¼

3Cos2qi  1=2; (2)
where qi is the angle between the C-D bond of the i-th segment and the
bilayer normal, and the brackets indicate the time ensemble average.
The mean-torque model developed by Petrache et al. (48) was used to
quantify the average area, hAi, per lipid (sn1) chain and the average hydro-
carbon thicknessDC per monolayer. For this, only the average S
i
CD at carbon
positions 2–6 was used.Biophysical Journal 96(9) 3762–3771RESULTS
SP-BCTERM in pure POPC lipids
First, the effects of SP-BCTERMon oriented bilayers composed
of pure POPC were investigated by acquiring 2H-NMR
spectra of oriented samples with varying peptide contents
(Fig. 1 a). In the absence of peptide, the peaks are well
resolved and show that the lipid bilayers are well aligned.
As peptide is added, the quadrupole splitting is observed to
decrease and the spectra become superpositions of more
than one component, one component with larger splittings,
corresponding to bilayers oriented with bilayer normal
parallel to the magnetic field and a second component having
features with splittings that are half of the oriented component
splittings (see arrows in Fig. 1 a). The second component is
most likely due to randomly oriented bilayers. Isotropically
reorienting structures such as micelles would give rise to an
unsplit feature of significant intensity at 0 kHz. The spectra
in Fig. 1 a suggest that any fraction of isotropic material
present in these samples must be very small.
31P spectra of the same samples were acquired to obtain
further insight into the effect of the peptide onboth the oriented
and unoriented components of the samples (Fig. 1 b). In the
absence of peptide, the 31P spectra exhibit a single peak at
34.2 ppm, corresponding to the s// peak. The signal intensity
in the spectral region spanning 0 and 20 ppm is negligible,
confirming that the lipid bilayers are well aligned with their
normals parallel to the external magnetic field. When peptide
at a concentration of 5% (w/w) is present in the POPC sample,
the chemical shift of the s// peak does not change appreciably,
but the intensity at s// decreases and a weak, broad peak
centered at ~12 ppm appears. When the concentration of
peptide in the sample is increased to 10%, the intensity of
s// is further decreased and the frequency is shifted downfield
to 38.0ppm. In otherwords, at 10%concentration the presence
of the peptide affects the conformation of the lipid headgroups
in the portion of the POPC sample that remains oriented.
For phosphatidylcholine and phosphatidylgylcerol, which
have isotropic chemical shift close to 0 ppm (49), theFIGURE 1 2H- (a) and 31P- (b) NMR spectra for POPC
(POPC/POPC-d31 ¼ 7/3, w/w) in the presence of
increasing concentrations of SP-BCTERM, where ‘‘/’’
and ‘‘0’’ indicate oriented and randomly orientated
species, respectively. The external magnetic field (B0) is
parallel to bilayer normal (n); B0 // n.
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significant intensity to the spectrum at stz s// / 2, the
chemical shift for bilayers oriented with their normal perpen-
dicular to the external field. Hence, if the lipid headgroup
orientation were the same in the oriented and unoriented frac-
tions of the samples, wewould expect the peaks deriving from
the unoriented lipids to appear at 17.1 and 19.0 ppm for
5% and 10% peptide, respectively. What is observed,
however, are peaks at 12 ppm for 5% peptide and 6
ppm for 10% peptide, and so it appears that the peptide
induces a different lipid headgroup conformation in the unor-
iented portion of the sample as compared to the oriented
lipids. This difference in conformation is slight at 5% but
more pronounced at 10% peptide. On the other hand, the 2H
splittings of the oriented fraction are double the splittings of
the unoriented fraction (Fig. 1 a) to within the precision
with which such splittings can be determined. That is to say,
even though the headgroup conformation is different in the
oriented and unoriented fractions of the sample, the acyl
chains in the oriented and unoriented fractions have the
same orientational order characteristics.
SP-BCTERM in pure POPG lipid
The quadrupole splittings in the 2H spectra of POPG (Fig. 2 a)
are smaller than those for POPC, indicating that the motion of
lipid acyl chains in POPG is less restricted. This presumably
reflects the effect of electrostatic repulsion of the charged
POPG headgroups on the average area per lipid. Similarly to
POPC, as peptide is added to the POPG bilayers the quadru-
pole splittings decrease and a second spectral component
with half the splittings, due to randomly oriented material,
appears. In contrast to POPC, the peaks in thePOPGþ peptide
spectra broaden significantly and become less resolved. This
may reflect a peptide-induced broadening of the distribution
of bilayer normal orientations about the direction of the
magnetic field, a contribution from the effects of strong
peptide-lipid interactions on relaxation time, or a combination
of both effects (50).Fig. 2 b shows the corresponding 31P spectra for POPG.
The inclusion of 5% peptide causes a downfield shift of
the s// peak from 31.4 ppm to 32.0 ppm, as well as a reduction
in this peak’s intensity, along with the appearance of a new
peak at ~4 ppm. The peptide’s effect on POPG is stronger
than its effect on POPC, as judged by the greater changes in
31P s// peak chemical shift and intensity for POPG, as well as
on the fraction of unoriented material and line-broadening
evident in the 2H spectra. The larger effect of the peptide
on the anionic POPG as compared to the zwitterionic
POPC is not unexpected given the peptide’s charge of þ3.
The wings at the base of the 31P s// peak with 5% peptide
(Fig. 2 b) support the conclusion that at least some of the
line-broadening observed in the 2H spectra is due to mosiac
spread of the bilayer stack. Although the new peak at
~4 ppm induced by the presence of 5% peptide is close
to the isotropic chemical shift, siso z 0 ppm, the
2H spec-
trum indicates no isotropically reorienting species, and thus
the 4 ppm peak can be attributed instead to randomly
oriented lipids. This st peak appears significantly downfield
of the chemical shift expected based on the s// peak (4 ppm
vs. st¼ s// / 2 ¼ 15.7 ppm), which indicates that
although the peptide interacts with both the oriented and
unoriented fractions of the lipids, it does not induce the
same headgroup conformation in each phase. The splittings
of the 2H spectra (Fig. 2 a) scale as expected at 5% peptide,
with the oriented material displaying splittings at twice the
unoriented splitting. However, at 10% peptide, the splittings
of the oriented lipids are noticeably smaller than twice the
unoriented splittings, indicating that the peptide has a differ-
ential effect on the lipid chains in the oriented and unoriented
fractions of the lipids.
At 10% peptide, the 31P spectrum changes greatly in char-
acter (Fig. 2 b) with two upfield peaks at 8.8 and10.5 ppm.
This type of patternwas observed in 31P spectra of lipids in the
presence of antimicrobial peptides and attributed to hexag-
onal phase material (51,52). However, this possibility can
be ruled out by the 2H spectrum (Fig. 2 a), which displays
no evidence of material with splittings at ~1/4 the orientedFIGURE 2 2H- (a) and 31P- (b) NMR spectra (at B0 // n)
for POPG (POPG/POPG-d31 ¼ 7/3, w/w) in the presence
of increasing concentrations of SP-BCTERM, where ‘‘/’’
and ‘‘0’’ indicate oriented and randomly orientated
species, respectively.Biophysical Journal 96(9) 3762–3771
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with cylindrical axes oriented parallel to the bilayer surface.
Although a hexagonal phase with cylindrical axes oriented
perpendicular to the bilayer surface would have intensity at
1/2 the oriented sample splitting, it is hard to imagine how
this would form without some cylinders aligned parallel to
the surface of the oriented layers. Instead, the 10.5 ppm
31P peak likely represents randomly oriented lipids, and the
peak at 8.8 ppm could indicate a population of oriented lipids
with a large peptide-induced change in average headgroup
orientation relative to the bilayer normal. A change from
32 to 8.8 ppm would correspond to a change in average
headgroup tilt of ~45 (49), which is well within the broad
distribution of tilt angles observed in simulations of PC bila-
yers (53,54) but is quite large; therefore, headgroup tilt may
not explain this shift in peak position. A large change in
headgroup tilt is supported by the decrease in chain order indi-
cated by the reduction in maximum 2H splitting with 10%
SP-BCTERM. The strong perturbation of the headgroups likely
generates a relatively wide distribution of headgroup orienta-
tions and therefore weakens the maximum intensity of the 31P
peaks, as observed.
SP-BCTERM in 7:3 POPC/POPG mixed lipid bilayers
In the next step of this work, we employed bilayers composed
of 7:3 POPC/POPG-d31 to characterize the effect of the
peptide on a model system with a headgroup composition
that is commonly used in LS research. In the absence of
peptide, the 2H peaks are well resolved, indicating well-
aligned bilayers (Fig. 3 a). Again, addition of the peptide
appears to broaden the spectral features associated with the
oriented bilayer component, and to introduce a second spec-
tral component with features at half the splitting of the corre-
sponding oriented spectral features. The second componentBiophysical Journal 96(9) 3762–3771is again attributed to peptide-induced disruption of the
bilayer orientation and the resulting formation of unoriented
bilayer material. Unlike in pure POPG, even at 10% peptide,
the splitting of the oriented component is close to double the
splitting of the powder component, indicating that the pertur-
bation of the POPG-d31 chains by SP-BCTERM is roughly
equivalent in the oriented and powder components of the
sample.
In the absence of SP-BCTERM, the
31P spectrum (Fig. 3 b)
indicates well-aligned lipid bilayers. The s// frequencies are
at ~36.7 ppm (for POPC) and 32.4 ppm (for POPG), with
an intensity ratio close to the 7/3 value expected given the lipid
composition of the sample. At high concentrations of peptide
(i.e., 2.5–10%), the s// peak of POPG-d31 is shifted upfield
by ~5 ppm to ~27 ppm,with amuch smaller upfield shift in the
s// peak of POPC. Similarly to the single lipid studies, addition
of peptide to the POPC/POPG-d31 mixture leads to a decrease
in the intensity of the s// peaks and a concomitant appearance
of intensity in the upfield portion of the spectra. However, the
effect of the peptide on the POPG-d31
31P peak intensity in the
POPC/POPG-d31 mixed samples (Fig. 3 b) is much smaller
than its effect on the POPG spectra in the sample with
POPG alone (Fig. 2 b), as judged by the position and intensity
of the s// peak. A comparison of the area under the deconvo-
luted s// peak (not shown) in the POPC/POPG-d31
31P spectra
to the areas in the single lipid samples indicates that the pres-
ence of POPG increases the effect of the peptide on the POPC,
and the presence of POPC decreases the effect of the peptide
on the POPG. For example, the ratio of areas for aligned PC, at
the s// frequency, in Fig. 3 b (POPC/POPG/peptide10%:
POPC/POPG/peptide0%) and Fig. 1 b (POPC/peptide10%:
POPC/peptide0%) is 0.3 (0.1) and 0.4 (0.1), respectively,
indicating that the POPC is more perturbed by the peptide
in the presence of 30% POPG than when POPC is the only
lipid present.FIGURE 3 2H- (a) and 31P- (b) NMR spectra (at B0 // n)
for mixed lipids POPC/POPG-d31 (¼ 7/3, w/w) in the
presence of increasing concentrations of SP-BCTERM.
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modes of lipid organization brought about by the presence of
SP-BCTERM give rise to a broad peak centered at ~12 ppm
at 1% peptide, but shifting toward 0 ppm at 5% and 10%
peptide. Although intensity at 0 ppm could reflect a population
of isotropically reorienting material, this possibility is elimi-
nated by the 2H spectra, and thus it likely reflects randomly
oriented material with a peptide-induced change in headgroup
conformation. The st peak is broader in POPC/POPG-d31
than in either of the single-lipid samples, indicating a larger
range of headgroup orientations in the unoriented fraction of
the mixed lipid sample. It is also centered more downfield
than either of the single lipid samples, indicating a different
average headgroup angle.
SP-BCTERM in BLES
Finally, the effect of SP-BCTERM on a near-complete LS was
probed with the use of BLES. The BLES samples were
analyzed by 31P-NMR because 31P is the naturally occurring
isotope. Deuterium NMR studies were not done, since such
studies would have involved perturbing the system by the
addition of 2H-labeled lipids.
In Fig. 4, the 31P spectra show the effect of SP-BCTERM on
oriented BLES. In the absence of peptide, the lipids in BLES
can be almost as well aligned as those in the POPC/POPG
sample, and the PC and PG peaks can be resolved. However,
unlike the POPC/POPG sample with 0% peptide, in BLES
a broad peak occurs at ~11 ppm even in the absence of
peptide. This small percentage of unaligned material is likely
due to the effect of the natural SP-B in the BLES, which is
~1% of the total surfactant (41). Indeed, the spectrum of
BLES with no additional peptide is very similar to the spec-
trum of POPC/POPG with 1% peptide (Fig. 3 b). Addition of
SP-BCTERM to the BLES leads to a significant increase in the
amount of randomly oriented material, with the s// peak
becoming indistinguishable at 7.5%. The appearance of the
31P spectrum at 7.5% peptide is very close to a purely
powder pattern spectrum, as expected for unoriented lipids,
with just a small amount of extra intensity remaining at
~32 ppm, indicating a small amount of residual orientation.
In contrast to the POPC/POPG samples, the new peaks
observed upon addition of the peptide do not appear near
0 ppm. Instead, they appear significantly upfield of this, at
~11 ppm, which is close to the st frequency of POPC
and POPG. There is also no discernible shift in the s//
peak from 0 to 2.5% peptide. Thus it appears that addition
of SP-BCTERM to BLES leads to loss of bilayer orientation,
but with no change of lipid headgroup conformation in either
the oriented or unoriented fractions of the sample.
DISCUSSION
SP-BCTERM disrupted the orientation of the mechanically
aligned bilayers in all of the systems studied, as demonstratedby the attenuation of the s//
31P peak with peptide addition
(Figs. 1 b, 2 b, 3 b, and 4, and Fig. S2 a). Such behavior is
likely related to SP-B’s ability to promote fusion of mono-
layers and bilayers, which must involve some sort of disrup-
tion to the regular multilayer structure. On the other hand,
SP-BCTERM did not induce the formation of small, rapidly
tumbling lipid structures, such as micelles, the observation
of which might lend support to a role for SP-B in promoting
insertion of the lipids into the air/water interface by inducing
lipid flip-flop transitions. Additionally, SP-BCTERM did not
induce formation of hexagonal phases, the observation of
which might support a role for SP-B in promoting lipid inser-
tion by stabilizing negatively curved lipid structures. It should
be noted, however, that the absence of such phenomena in the
fluid lipid phases employed in this study does not necessarily
mean they are not possible in the highly compressed lipid
phases present in the lungs upon expiration.
Like SP-BCTERM, full-length SP-B has an overall positive
charge, which has led others to examine the potential prefer-
ence of SP-B for anionic lipids. No consensus has yet been
reached; in some studies a preference for DPPG over DPPC
was observed (55,56), whereas in others SP-B appeared to
FIGURE 4 31P spectra (at B0 // n) for BLES in the presence of increasing
concentrations of SP-BCTERM.Biophysical Journal 96(9) 3762–3771
3768 Yang et al.preferentially associate with DPPC over DPPG (57,58),
presumably due to exclusion of the peptide from the more
condensed DPPG domains. In this study, SP-BCTERM
certainly had a greater effect on pure POPG than pure
POPC, as judged by loss of oriented material (as assessed
by reductions in area under the s//
31P peak and increases
in the 2H spectral component with smaller splittings), by
changes in headgroup orientation in both the oriented and
unoriented fractions of the sample, and by increases in 2H
linewidth in POPG samples with peptide (Figs. 1 and 2).
In 7:3 POPC/POPG, SP-BCTERM appeared to preferentially
affect the POPG component, as it was seen to induce greater
area and chemical shift changes in the oriented (s//) PG
peak compared to the PC peak in the 31P spectra (Fig. 3
b and Fig. S2). A comparisonwith the single lipid results indi-
cated that the presence of POPC in the lipid mixture reduced
the effect of the peptide on POPG as compared to POPG
alone, and vice versa. At 5% peptide, the degree of orientation
disruption was comparable for POPG, POPC/POPG, and
BLES, but at 2.5% peptide, BLES experienced more disrup-
tion than POPC/POPG. In contrast to the POPC/POPGmodel
system, BLES contains ~45% saturated lipid chains and only
~10% anionic lipids, as well as SP-B, SP-C, and other lipid
components (59). Thus, it appears that although headgroup
charge is an important factor in determining the degree of
disruption, other components present in BLES likely also
modulate the peptide-induced disruption.
SP-BCTERM is similar in overall topology to a large class of
antimicrobial peptides with predominantly helical, amphi-
pathic, cationic structure, which also function bymechanisms
that involve disruption of bilayer structure. Full-length SP-B
is member of the saposin superfamily, which contains several
proteins with antimicrobial activities (60). Although full-
length SP-B and peptide fragments of SP-B do display antimi-
crobial activity in laboratory assays for this characteristic, it
is not thought to contribute to SP-B’s in vivo role, since
the antimicrobial activity is not specific for pathogenic
membranes and is inhibited by surfactant lipids (61). Overall,
the degree of peptide-induced orientation disruption observed
for SP-BCTERM was near the more severe end of the spectrum
of disruption observed for helical antimicrobial peptides
that have been studied with similar methods (52,62), asBiophysical Journal 96(9) 3762–3771judged by the significant reduction of oriented species in the
31P spectra.
As well as disrupting bilayer orientation, SP-BCTERM also
affects the configuration of the portion of the lipids in the
sample that remain oriented, at least in the model lipid
systems. This can be seen in the changes in the position of
the s//
31P peak in the POPC, POPG, and POPC/POPG
samples (Figs. 1 b, 2 b, 3 b, and Fig. S2), which indicate
changes in headgroup conformation in the oriented portion
of the sample. It should be emphasized that peptide-induced
shifts in the s// peaks of BLES were not observed, indicating
that although SP-BCTERM leads to levels of orientation disrup-
tion inBLES similar to those seen in themodel systems, it does
so without any apparent effect on lipid headgroup orientation.
The effect of the peptide on the oriented fraction of the
model lipid samples is also seen in the reduction of quadru-
pole splittings of the oriented component of the 2H spectra
(Figs. 1 a, 2 a, and 3 a), which indicates a decreased acyl
chain order of the oriented fraction of the samples in the pres-
ence of peptide. To quantify the effect of the peptide on chain
order at different positions along the chain, order parameter
profiles were extracted from the 2H spectra (Fig. 5). For the
POPC-d31 and POPC/POPG-d31 samples, it was possible to
extract the order parameters using only the 2H signals
contributed by the oriented fraction of the sample, although
due to the broader linewidths in the POPG-d31/peptide
spectra, the same analysis was not possible for those
samples. The order parameter of the chains decreases with
increasing peptide content, with the largest effects at approx-
imately carbon 11 (see Fig. 5 and the fractional order param-
eter profiles in Fig. S3), indicating that the peptide affects
acyl chain order deep within the bilayer. In the C10-C12
region of the order parameter profile, the peptide seems to
have a greater effect on POPC-d31 than on the POPC/
POPG-d31 mix (Fig. 5 and Fig. S3). This can potentially
be explained if the peptide positions more deeply in the
POPC/POPG bilayer and restricts chain motion, as opposed
to a more peripheral interaction of the peptide with POPC,
which would push the headgroups apart, allowing more
freedom of motion for the acyl chains (63).
The order parameters in the plateau region (i.e., C2–6) are
most indicative of lipid average area and were used toFIGURE 5 Order parameter profile, jSCDij, of the sn1
chains of POPC-d31 (a), and POPG-d31 in POPC/POPG-
d31 (¼ 7/3, w/w) (b) in the presence of increasing concen-
trations of SP-BCTERM, as derived from Figs. 1 a and 3 a,
respectively. The gray color of some of the markers indi-
cates that these values were derived from clearly identifi-
able oriented peaks from 2H spectral regions that were
composed of superpositions of oriented and unoriented
spectra.
NMR of SP-BCTERM in Oriented Bilayers 3769or POPG alone. The POPC/POPG st peak is also much
broader than in either of the single lipid samples, indicating
a broader range of lipid headgroup orientations. Notably, in
BLES there is no apparent perturbation of lipid headgroup
orientation by SP-BCTERM on the oriented fraction of the
lipids, and the unoriented fraction of the sample also conforms
well to the expected 31P chemical shift. In other words,
SP-BCTERM disrupts the orientation of the BLES bilayers
without having any measurable impact on the headgroup
conformation.
In comparison with earlier studies of full-length SP-B in
DPPC or DPPC/DPPG vesicles (64–66), the effect of peptide
SP-BCTERM on lipids, including BLES, was much stronger in
the study presented here, especially in terms of lipid order
parameter, even though the concentrations of SP-B used in
the earlier studiesweremuch higher (up to 17wt%) compared
to the SP-BCTERM in this study. The differencemight be attrib-
uted to the effect of the N-terminal region of SP-B, i.e., the
rest of the SP-B weakening the interaction with the lipids.
However, the high degree of similarity in the 31P spectra of
BLES, which contains ~1% SP-B, and POPC/POPG, with
1%SP-BCTERM, argues for a similarity in the lipid interactions
of SP-BCTERM and its parent protein, full-length SP-B.
Alternatively, the source of the greater acyl chain parameter
disruptions observed in this study may be explained by the
differences in the levels of chain unsaturation present: in the
earlier studies the chains were 100% saturated, whereas in
this study they were either 100% asymmetric lipids with
one unsaturated chain, as in the model lipid systems, or, in
the case of the BLES study, still contained a significant frac-
tion of unsaturated lipids (~55%) (41).
Lipid chain saturation is clearly a critical factor in modu-
lating LS activity. In this study we used only unsaturated
lipids in the model lipid systems, which allowed us to probe
the effect of the lipid headgroups on the protein-bilayer inter-
actions in the absence of chain saturation effects. However,
although LS has a high unsaturated lipid content, the satu-
rated lipid DPPC is clearly key in LS function (3,11). The
31P spectra with BLES give an indication of how compo-
nents of natural LS, especially DPPC and SP-C, modulate
the effects of SP-BCTERM on lipids. Although SP-BCTERM
had very similar effects on BLES and on the model POPG/calculate the average area, <A>, and thickness, DC, of the
saturated (sn1) acyl chain of the lipids using the mean torque
method developed by Petrache et al. (48). In the absence of
peptide, the average area per POPC-d31 lipid in POPC-only
bilayers and that of POPG-d31 in POPC/POPG-d31 mixed
bilayers was very similar (a). On the other hand, the area
per lipid of POPG-d31 in POPG-only bilayers is significantly
larger, as expected given the electrostatic repulsion between
POPG headgroups. The addition of a small amount of
peptide (1% w/w) led to a large change in the area per
POPG-d31 lipid in POPC/POPG-d31. At 5% peptide, the
lipid area of POPC/POPG-d31 was ~1 A˚
2 greater than in
POPC-d31, supporting the idea that electrostatic interactions
lead to a greater impact of the peptide on the lipid area in
anionic lipid-containing bilayers. At 10% peptide, the lipid
area in POPC/POPG-d31 was only slightly higher than for
POPC, which may indicate that this is close to the maximum
area that both lipids can reach before their alignment is
significantly disrupted. As the lipid acyl chains increase in
area and experience more freedom of motion, there is a cor-
responding reduction in the thickness of the lipid chain area,
as shown in Fig. 6 b.
SP-BCTERM interacts with both the oriented and unoriented
fraction of lipids in the samples, but it does not, in general,
induce the same lipid conformation in both fractions. This
result follows from comparing the 31P and 2H spectral features
observed for the unoriented portion of the samples with what
is predicted based on the oriented spectra (i.e., st¼ s// / 2
for 31P, and unoriented splittings ¼ half oriented splittings
for 2H). Addition of peptide to pure POPC or pure POPG bila-
yers results in a relatively narrow 31P st peak that does not
follow well the expected scaling based on the position of
the s// peak, indicating that the conformation of the lipid head-
groups is different in the oriented and unoriented fractions of
the sample. Although the 2H spectra match the expected
scaling better, there does appear to be a discrepancy in the
10% peptide þ POPG samples, indicating differences in the
lipid acyl chain order in the oriented and unoriented fractions
of this sample. In the POPC/POPGmix, the unoriented mate-
rial displays a st peak close to the expected position at low
peptide concentrations, but at high concentrationsst deviates
from the expectation even more than is seen in either POPCFIGURE 6 (a) Average area, <A>, of saturated (sn1)
lipid acyl chains, and (b) DC, average lipid hydrocarbon
thickness per monolayer, of POPC-d31 and POPC/POPG-
d31 as a function of SP-BCTERM concentration. Because
of the disruptive effect of the peptide on the spectra of
POPG-d31 bilayers, only the data at 0% peptide are shown
for the POPG-only samples.Biophysical Journal 96(9) 3762–3771
3770 Yang et al.POPC system in some respects (for example, on the degree
of bilayer disruption), there was a major difference in the
peptide’s effects on the two systems in that the peptide
perturbed lipid headgroup orientation in the model system
but not in BLES. Further work is needed to elucidate the
functional interactions present in natural LS, especially the
effects of the saturated lipids, SP-C, and cholesterol, and to
further probe the orientation and depth of SP-BCTERM within
the bilayers.
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